open access

Vol 27, No 2 (2020)
Technology note — Interventional cardiology
Submitted: 2019-04-02
Accepted: 2019-06-24
Early publication date: 2019-09-26
Get Citation

SAPIEN 3 Ultra — Design and procedural features of a new balloon-expandable valve

Radosław Parma1, Damian Hudziak2, Grzegorz Smolka1, Radosław Gocoł2, Andrzej Ochała1, Wojciech Wojakowski1
DOI: 10.5603/CJ.a2019.0096
·
Pubmed: 31565790
·
Cardiol J 2020;27(2):194-196.
Affiliations
  1. Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland, Poland
  2. Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland, Ziolowa 45, 40-635 Katowice, Poland

open access

Vol 27, No 2 (2020)
Technology note — Interventional cardiology
Submitted: 2019-04-02
Accepted: 2019-06-24
Early publication date: 2019-09-26

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

transcatheter heart valve, TAVI

About this article
Title

SAPIEN 3 Ultra — Design and procedural features of a new balloon-expandable valve

Journal

Cardiology Journal

Issue

Vol 27, No 2 (2020)

Pages

194-196

Early publication date

2019-09-26

Page views

1278

Article views/downloads

621

DOI

10.5603/CJ.a2019.0096

Pubmed

31565790

Bibliographic record

Cardiol J 2020;27(2):194-196.

Keywords

transcatheter heart valve
TAVI

Authors

Radosław Parma
Damian Hudziak
Grzegorz Smolka
Radosław Gocoł
Andrzej Ochała
Wojciech Wojakowski

References (4)
  1. Solomonica A, Choudhury T, Bagur R. Newer-generation of Edwards transcatheter aortic valve systems: SAPIEN 3, Centera, and SAPIEN 3 Ultra. Expert Rev Med Devices. 2019; 16(2): 81–87.
  2. Daubert MA, Weissman NJ, Hahn RT, et al. Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial. JACC Cardiovasc Imaging. 2016 [Epub ahead of print].
  3. Kapadia SR, Leon MB, Makkar RR, et al. PARTNER trial investigators. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986): 2485–2491.
  4. Hahn RT, Pibarot P, Leipsic J, et al. The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry. JACC Cardiovasc Interv. 2018; 11(17): 1710–1718.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl